Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baer

Showing results (361-370 of 628) with videos related to

Pageof 63
Sort By:
Biochemistry|April 5, 1977
Specificity of the phosphatidylcholine exchange protein from bovine liverH H Kamp, W A Wirtz, P R Baer, et al.
Molecular and Cellular Biology|February 1, 1994
Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteinsH L Hsu, L Huang, J T Tsan, et al.
Cancer Genetics and Cytogenetics|January 1, 1988
An acquired Robertsonian translocation dic(14;14)(p11;p11) in a patient with a myelodysplastic syndrome following treatment of multiple myelomaY S Fan, M R Baer, S N Sait, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|April 11, 2013
Influence of Aging and Environment on Nanoparticle Chemistry - Implication to Confinement Effects in NanoceriaSatyanarayana Vnt Kuchibhatla, A S Karakoti, D R Baer, et al.
Leukemia & Lymphoma|November 9, 2001
Acute myeloid leukemia in the setting of low dose weekly methotrexate therapy for rheumatoid arthritisB Kolte, A N Baer, S N Sait, et al.
Haematology and Blood Transfusion|January 1, 1989
Chromosomal translocations involving the T-cell receptor delta chain locus and two loci on the short arm of chromosome 11T Boehm, R Baer, L Buluwela, et al.
Molecular Cancer Research : MCR|April 2, 2015
c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated LeukemiasNidal Muvarak, Shannon Kelley, Carine Robert, et al.
Haematologica|January 3, 2012
Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromesAmy J Davidoff, Sheila Weiss Smith, Maria R Baer, et al.
Molecular Cancer Therapeutics|June 16, 2005
In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cellsHans Minderman, Jeffrey M Conroy, Kieran L O'Loughlin, et al.
Molecular Cancer Therapeutics|July 11, 2012
The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2Rupashree Sen, Karthika Natarajan, Jasjeet Bhullar, et al.
Pageof 63

Showing results (361-370 of 628) with videos related to

Sort By:
Pageof 63
Biochemistry|April 5, 1977
Specificity of the phosphatidylcholine exchange protein from bovine liverH H Kamp, W A Wirtz, P R Baer, et al.
Molecular and Cellular Biology|February 1, 1994
Preferred sequences for DNA recognition by the TAL1 helix-loop-helix proteinsH L Hsu, L Huang, J T Tsan, et al.
Cancer Genetics and Cytogenetics|January 1, 1988
An acquired Robertsonian translocation dic(14;14)(p11;p11) in a patient with a myelodysplastic syndrome following treatment of multiple myelomaY S Fan, M R Baer, S N Sait, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|April 11, 2013
Influence of Aging and Environment on Nanoparticle Chemistry - Implication to Confinement Effects in NanoceriaSatyanarayana Vnt Kuchibhatla, A S Karakoti, D R Baer, et al.
Leukemia & Lymphoma|November 9, 2001
Acute myeloid leukemia in the setting of low dose weekly methotrexate therapy for rheumatoid arthritisB Kolte, A N Baer, S N Sait, et al.
Haematology and Blood Transfusion|January 1, 1989
Chromosomal translocations involving the T-cell receptor delta chain locus and two loci on the short arm of chromosome 11T Boehm, R Baer, L Buluwela, et al.
Molecular Cancer Research : MCR|April 2, 2015
c-MYC Generates Repair Errors via Increased Transcription of Alternative-NHEJ Factors, LIG3 and PARP1, in Tyrosine Kinase-Activated LeukemiasNidal Muvarak, Shannon Kelley, Carine Robert, et al.
Haematologica|January 3, 2012
Patient and physician characteristics associated with erythropoiesis-stimulating agent use in patients with myelodysplastic syndromesAmy J Davidoff, Sheila Weiss Smith, Maria R Baer, et al.
Molecular Cancer Therapeutics|June 16, 2005
In vitro and in vivo irinotecan-induced changes in expression profiles of cell cycle and apoptosis-associated genes in acute myeloid leukemia cellsHans Minderman, Jeffrey M Conroy, Kieran L O'Loughlin, et al.
Molecular Cancer Therapeutics|July 11, 2012
The novel BCR-ABL and FLT3 inhibitor ponatinib is a potent inhibitor of the MDR-associated ATP-binding cassette transporter ABCG2Rupashree Sen, Karthika Natarajan, Jasjeet Bhullar, et al.
Pageof 63